-
Hepatitis C Virus in Turkey
Emerging Markets, May, 2013
The Turkish government has heavily invested in healthcare
over the past two decades, which results in sustained growth in the Turkish
pharmaceutical market....
-
Breast Cancer in the BRIC Markets
Emerging Markets, December, 2012
Over the next nine years,
the diagnosed incidence of CaB in the BRIC (Brazil, Russia, India and China) will
grow at almost three times the average annual...
-
Breast Cancer in Mexico
Emerging Markets, November, 2012
Over the next decade, the diagnosed incidence of breast
cancer (CaB) in Mexico will increase at almost three times the average annual
growth rate in the major...
-
Atrial Fibrillation in Brazil
Emerging Markets, November, 2012
Atrial fibrillation (AF) is the most
common cardiac arrhythmia encountered in clinical practice. The disease represents
an area of significant unmet need in...
-
Atrial Fibrillation in China
Emerging Markets, November, 2012
Atrial fibrillation (AF) is the most
common cardiac arrhythmia encountered in clinical practice. The disease continues
to represent an area of significant...
-
Type 2 Diabetes in South Korea
Emerging Markets, October, 2012
South Korea has one of the most advanced healthcare systems
in the world and a rapidly expanding pharmaceutical market. Combined with
increasing awareness of...
-
Prostate Cancer in Russia
Emerging Markets, September, 2012
The incidence of prostate
cancer (CaP) in Russia is the second highest among the BRIC countries (Brazil,
Russia, India, China). Russia will experience a...
-
Non-Small-Cell Lung Cancer in China
Emerging Markets, July, 2012
China is one of the most rapidly growing pharmaceutical
markets in the world, and it has a vast, rapidly expanding prevalent population
of non-small-cell lung...
-
Colorectal Cancer in Russia
Emerging Markets, May, 2012
The incidence of colorectal
cancer (CRC) in Russia is the highest among the BRIC (Brazil, Russia, India,
China) markets and is comparable to that of the United...
-
Colorectal Cancer in China
Emerging Markets, March, 2012
China has one of the most
rapidly growing pharmaceutical markets in the world, as well as a vast, rapidly
expanding prevalent population of colorectal cancer...
-
Non-Small-Cell Lung Cancer in Russia
Emerging Markets, December, 2011
The incidence of
non-small-cell lung cancer (NSCLC) in Russia is the highest among the BRIC
(Brazil, Russia, India, China) markets, and is comparable to that...
-
Acute Coronary Syndrome in Brazil
Emerging Markets, November, 2011
Acute coronary syndrome (ACS)—an umbrella term that
encompasses acute ST-elevation myocardial infarction (STEMI), non-ST-elevation
myocardial infarction...
-
Acute Coronary Syndrome in China
Emerging Markets, November, 2011
Acute coronary syndrome (ACS)—an umbrella
term that encompasses acute ST-elevation myocardial infarction (STEMI),
non-ST-elevation myocardial infarction...
-
Hepatitis C Virus in Mexico
Emerging Markets, November, 2011
Unlike the major markets, changes in the population
structure of Mexico will lead to an increase in the size of the prevalent hepatitis
C virus (HCV)...
-
Type 2 Diabetes in Russia
Emerging Markets, October, 2011
The increasingly dynamic Russian market for type 2 diabetes
therapies offers significant opportunity to multinational companies (MNCs) with
emerging therapies...
-
Gastric Cancer in China
Emerging Markets, June, 2011
China is one of the most rapidly growing pharmaceutical
markets in the world. Currently, China’s incidence of gastric cancer (GC) is one
of the highest in the...
-
Hepatitis B Virus in China
Emerging Markets, June, 2011
China is one of the world’s most rapidly growing
pharmaceutical markets. It has a vast prevalent population of hepatitis B virus
(HBV)-infected patients, a...
-
Prostate Cancer in Brazil
Emerging Markets, May, 2011
The increasingly dynamic Brazilian market for prostate
cancer (CaP) therapies offers significant opportunity to multinational companies
(MNCs) with emerging...
-
Colorectal Cancer in Brazil
Emerging Markets, May, 2011
The large and growing Brazilian market for colorectal cancer
(CRC) therapies offers significant opportunity to multinational companies
(MNCs) with current or...
-
Hepatitis C Virus in China
Emerging Markets, March, 2011
China has the largest prevalent population of hepatitis C
virus (HCV) patients in the world, as well as a fast-growing pharmaceutical
market. Supported by...